Art

J-GLOBAL ID：201102265069771690   Reference number：11A0422033

Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis

原発性骨髄線維症において低用量サリドマイド+プレドニゾロンの併用療法で軽減する血球減少症の前向き試験

Author (8)： HATTORI Yutaka (Keio Univ., Tokyo, JPN) ,  MIYAKAWA Yoshitaka (Keio Univ. School of Medicine, Tokyo, JPN) ,  YOKOYAMA Kenji (Keio Univ. School of Medicine, Tokyo, JPN) ,  YAMADA Taketo (Keio Univ. School of Medicine, Tokyo, JPN) ,  DU Wenlin (Keio Univ. School of Medicine, Tokyo, JPN) ,  JINZAKI Masahiro (Keio Univ. School of Medicine, Tokyo, JPN) ,  SHINMOTO Hiroshi (Keio Univ. School of Medicine, Tokyo, JPN) ,  OKAMOTO Shinichiro (Keio Univ. School of Medicine, Tokyo, JPN)
Material： International Journal of Hematology  (Int J Hematol)
Volume： 93  Issue： 1  Page： 129-131  Publication year： Jan. 2011 
JST Material Number： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  Document type： Article
Article type： 短報  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *myelofibrosis ,...
Semi thesaurus term： *Primary Myelofibrosis

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0422033&from=J-GLOBAL&jstjournalNo=F0888A") }}

JST classification (1)： Clinical hematology in general  (GK01030Y)

Substance index (2)： Thalidomide ,  Prednisolone

Reference (10)：

• BAROSI, G. Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia. Br J Haematol. 2001, 114, 78-83
• PICCALUGA, PP. Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study. Leukemia. 2002, 16, 1609-1614
• MARCHETTI, M. Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia : a phase II trial. J Clin Oncol. 2004, 22, 424-431
• STRUPP, C. Thalidomide for the treatment of idiopathic myelofibrosis. Eur J Haematol. 2004, 72, 52-57
• ABGRALL, JF. Thalidomide versus placebo in myeloid metaplasia with myelofibrosis : a prospective, randomized, double-blind, multicenter study. Haematologica. 2006, 91, 1027-1032

Terms in the title (7)： 原発性骨髄線維症 ,  低用量 ,  サリドマイド ,  プレドニゾロン ,  併用療法 ,  血球減少症 ,  試験